WIndow Therapeutics discovers and develops transformational therapeutics for cancer.
WIndow Therapeutics has raised $256K in total funding. The most recent round was Grant. The last funding was announced in February 2022.
WIndow Therapeutics's investors include National Science Foundation.
WIndow Therapeutics is headquartered in Boston, United States.
WIndow Therapeutics discovers and develops transformational therapeutics for cancer.
WIndow Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"WIndow Therapeutics — Funding & Investors." VCBacked, February 24, 2022, https://www.vcbacked.co/company/window-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). WIndow Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/window-therapeutics
{{cite web |title=WIndow Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/window-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated